Cell therapy weekly: NICE recommends pioneering CAR-T therapy for patients with lymphoma

This week: an autologous CAR-T therapy has been recommended by the National Institute for Health and Care Excellence (NICE; UK) for patients with lymphoma, RheinCell Therapeutics (Langenfeld, Germany) has received a GMP certification to manufacture cord blood-derived iPSCs, RoosterBio (MD, USA) and Sartorius (Göttingen, Germany) partner to advance the scale-up of human mesenchymal cell/stromal cell manufacturing, and a next-generation jellyfish collagen hydrogel has been developed for in vitro cell culture and tissue engineering. The news highlights: NICE recommends pioneering CAR-T therapy for patients with lymphoma RheinCell achieves GMP certification to manufacture cord blood-derived iPSCs RoosterBio and Sartorius partner to advance...